The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Drug Prescription Patterns in Patients With Addison's Disease: A Swedish Population-Based Cohort Study
Abstract
CONTEXT: There are no published data on drug prescription in patients with Addison's disease (AD). OBJECTIVE: Our objective was to describe the drug prescription patterns in Swedish AD patients before and after diagnosis compared with population controls. DESIGN AND SETTING: We conducted a population-based cohort study in Sweden. PATIENTS: Through the Swedish National Patient Register and the Swedish Prescribed Drug Register, we identified 1305 patients with both a diagnosis of AD and on combination treatment with hydrocortisone/cortisone acetate and fludrocortisone. Direct evidence of the AD diagnosis from patient charts was not available. We identified 11 996 matched controls by the Register of Population. MAIN OUTCOME MEASURE: We determined the ratio of observed to expected number of patients treated with prescribed drugs. RESULTS: Overall, Swedish AD patients received more prescribed drugs than controls, and 59.3% of the AD patients had medications indicating concomitant autoimmune disease. Interestingly, both before and after the diagnosis of AD, patients used more gastrointestinal medications, antianemic preparations, lipid-modifying agents, antibiotics for systemic use, hypnotics and sedatives, and drugs for obstructive airway disease (all P values < .05). Notably, an increased prescription of several antihypertensive drugs and high-ceiling diuretics was observed after the diagnosis of AD. CONCLUSION: Gastrointestinal symptoms and anemia, especially in conjunction with autoimmune disorders, should alert the physician about the possibility of AD. The higher use of drugs for cardiovascular disorders after diagnosis in patients with AD raises concerns about the replacement therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with adrenal insufficiency are at an increased risk of infection”
From ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency (2020) · cites this paper as [9]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055 · cited 1×
“The SNPR contains information on dates of hospital admission and discharge, codes for all surgical procedures and discharge diagnoses (12).”
BackgroundSelf-citationStatistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
(1998) · PubMed · Cited by 2,737
The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
Ludvigsson, J. F., Otterblad-Olausson, P., Pettersson, B. U., & Ekbom, A. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9350-y · Cited by 2,403 · cited 1×
“Data in registries can be linked to each other through the unique personal identity number assigned to all Swedish residents (15).”
BackgroundSelf-citationWettermark, B., Hammar, N., MichaelFored, C., Leimanis, A., Otterblad Olausson, P., Bergman, U., Persson, I., Sundström, A., Westerholm, B., & Rosén, M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1294 · Cited by 1,887 · cited 1×
“The Swedish Prescribed Drug Register (SPDR) has been gathering data since July 2005 on all drugs dispensed by prescription to the whole Swedish population (eg, dispensed quantity, dosage, expenditure, and reimbursement) (13).”
BackgroundSelf-citationBetterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758
Autoimmune Polyendocrine Syndromes
Eisenbarth, G. S., & Gottlieb, P. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030158 · Cited by 672
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Statistical Methods in Cancer Research, Vol. II: The Design and Analysis of Cohort Studies.
Machin, D., Breslow, N. E., & Day, N. E. (1990) · Biometrics · doi:10.2307/2532481 · Cited by 634
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490 · cited 2×
“Reduced health status and working ability (7, 8) as well as increased mortality have been reported (9, 10) in AD.”
BackgroundResultErichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422 · cited 4×
“Recent data from Germany shows that as many as 20% of patients with primary or secondary adrenal insufficiency had symptoms for more than 5 years before diagnosis.”
BackgroundResultInfluentialZöller, B., Li, X., Sundquist, J., & Sundquist, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61306-8 · Cited by 366 · cited 1×
“The authors suggested that the inflammatory activity of the disorder could cause the hypercoagulability (29).”
BackgroundHahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282 · cited 3×
“Previous studies have suggested that patients with AD have difficulties coping with emotional stress and increased anxiety (7, 8).”
BackgroundSubjective health status in Norwegian patients with Addison’s disease.
Løvås, K., Loge, J. H., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01466.x · Cited by 256
Omeprazole Therapy Causes Malabsorption of Cyanocobalamin (Vitamin B12)
Marcuard, S. P., Albernaz, L., & Khazanie, P. G. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00006 · Cited by 251 · cited 1×
“This can be due to pernicious anemia, which is known to be more common in AD patients because it is most often caused by an autoimmune gastritis, but it may also be due to the increased use of proton pump inhibitors (20).”
BackgroundDelayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients
Bleicken, B., Ventz, M., Quinkler, M., & Hahner, S. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181db6b7a · Cited by 242 · cited 8×
“2012-3561 J Clin Endocrinol Metab, May 2013, 98(5):2009–2018 jcem.”
BackgroundMethodInfluentialBensing, S., Brandt, L., Tabaroj, F., Sjöberg, O., Nilsson, B., Ekbom, A., Blomqvist, P., & Kämpe, O. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03340.x · Cited by 242 · cited 2×
“Reduced health status and working ability (7, 8) as well as increased mortality have been reported (9, 10) in AD.”
BackgroundResultSelf-citationHigh nationwide prevalence of multiple sclerosis in Sweden
Ahlgren, C., Odén, A., & Lycke, J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511403794 · Cited by 220 · cited 1×
“Sweden is known to have high incidences and prevalence of several autoimmune diseases (39, 40).”
BackgroundGlucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205 · cited 1×
“Conventional glucocorticoid replacement doses could be too high (21) and/or delivered in a nonphysiological pattern (22).”
BackgroundLong-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial
Gurnell, E. M., Hunt, P. J., Curran, S. E., Conway, C. L., Pullenayegum, E. M., Huppert, F. A., Compston, J. E., Herbert, J., & Chatterjee, V. K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1134 · Cited by 189 · cited 1×
“Untreated androgen deficiency could also be a contributing factor to high blood lipids after diagnosis, even though the effects of dehydroepiandrosterone replacement therapy on body composition and insulin sensitivity are controversial (25, 26).”
BackgroundGlucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone
Løvås, K., Gjesdal, C. G., Christensen, M., Wolff, A. B., Almås, B., Svartberg, J., Fougner, K. J., Syversen, U., Bollerslev, J., Falch, J. A., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0880 · Cited by 163
The prevalence of Addison's disease in Coventry, UK
Willis, A., & VINCE, F. P. (1997) · Postgraduate Medical Journal · doi:10.1136/pgmj.73.859.286 · Cited by 150
Why is the management of glucocorticoid deficiency still controversial: a review of the literature
Crown, A. L., & Lightman, S. L. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02320.x · Cited by 136 · cited 1×
“Conventional glucocorticoid replacement doses could be too high (21) and/or delivered in a nonphysiological pattern (22).”
BackgroundDahlquist, G., Mustonen, L., & for the Swedish Childhood Diabetes Study Group (2000) · Acta Paediatrica · doi:10.1080/080352500750027628 · Cited by 122 · cited 1×
“Sweden is known to have high incidences and prevalence of several autoimmune diseases (39, 40).”
BackgroundAlimohammadi, M., Dubois, N., Sköldberg, F., Hallgren, Å., Tardivel, I., Hedstrand, H., Haavik, J., Husebye, E. S., Gustafsson, J., Rorsman, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809986106 · Cited by 113 · cited 1×
“Significant pulmonary disease has been observed in the rare syndrome APS 1 and is correlated to autoantibodies directed against the potassium channel regulatory protein (KCNRG) in epithelial cells of terminal bronchioles (30).”
BackgroundSelf-citationDahlquist, G. G., Mustonen, L., & for the Swedish Childhood Diabetes Study Group (2000) · Acta Paediatrica · doi:10.1111/j.1651-2227.2000.tb00741.x · Cited by 104
BECKER, C. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-3-432 · Cited by 100 · cited 1×
“Concomitant autoimmune manifestations such as hypothyroidism are associated with high blood lipids and increased risk of atherosclerotic diseases (27).”
BackgroundGarcía-Borreguero, D., Wehr, T. A., Larrosa, O., Granizo, J. J., Hardwick, D., Chrousos, G. P., & Friedman, T. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6965 · Cited by 91 · cited 1×
“One study from Norway with 64 AD patients showed that most patients did not have clinically important sleep disturbances (32), whereas a study from the United States reported reduced quality of sleep in AD patients (33).”
BackgroundRisk of hip fracture in Addison’s disease: a population-based cohort study
Björnsdottir, S., Sääf, M., Bensing, S., Kämpe, O., Michaëlsson, K., & Ludvigsson, J. F. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02352.x · Cited by 85
Self-citationGiordano, R., Marzotti, S., Balbo, M., Romagnoli, S., Marinazzo, E., Berardelli, R., Migliaretti, G., Benso, A., Falorni, A., Ghigo, E., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345773 · Cited by 84
Addison’s Disease in Women Is a Risk Factor for an Adverse Pregnancy Outcome
Björnsdóttir, S., Cnattingius, S., Brandt, L., Nordenström, A., Ekbom, A., Kämpe, O., & Bensing, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0108 · Cited by 82 · cited 1×
“In addition, awareness of the increased risk of POF and reduced parity (37, 38) may influence patients and physicians to use and prescribe less oral contraceptive.”
BackgroundSelf-citationSexuality and Fertility in Women with Addison’s Disease
Erichsen, M. M., Husebye, E. S., Michelsen, T. M., Dahl, A. A., & Løvås, K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0445 · Cited by 71 · cited 1×
“In addition, awareness of the increased risk of POF and reduced parity (37, 38) may influence patients and physicians to use and prescribe less oral contraceptive.”
BackgroundAdrenal autoantibodies and organ‐specific autoimmunity in patients with Addison's disease
Söderbergh, A., Winqvist, O., Norheim, I., Rorsman, F., Husebye, E. S., Dolva, Ø., Karlsson, F. A., & Kämpe, O. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8040813.x · Cited by 66 · cited 1×
“We found that 59% of AD patients had medications indicating concomitant common APS 2 manifestations, which is in accordance with previous studies (18, 41).”
ResultSelf-citationSleep disturbances in patients with Addison's disease
Løvås, K., Husebye, E., Holsten, F., & Bjorvatn, B. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480449 · Cited by 55
Epidemiologic study of adrenal gland disorders in Japan
Takayanagi, R., Miura, K., Nakagawa, H., & Nawata, H. (2000) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(00)80036-0 · Cited by 43 · cited 1×
“The lowest occurrence, 5 cases per million, has been reported in Japan (4) and the highest, 144 cases per million, in Norway (3).”
BackgroundReplacement therapy for Addison's disease: recent developments
Løvås, K., & Husebye, E. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.497 · Cited by 40
Fine tuning for quality of life: 21st century approach to treatment of Addison’s disease
Reisch, N., & Arlt, W. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.01.008 · Cited by 36 · cited 1×
“The causes of these findings have not been fully elucidated, but there is a concern that the currently accepted replacement regime may be suboptimal (11).”
BackgroundA nationwide cohort study of the risk of chronic obstructive pulmonary disease in coeliac disease
Ludvigsson, J. F., Inghammar, M., Ekberg, M., & Egesten, A. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02448.x · Cited by 30 · cited 1×
“In addition, a recent study on patients with celiac disease found a moderately increased risk of chronic obstructive pulmonary disease both before and after diagnosis (31).”
BackgroundSelf-citationReversibility of gastric dysmotility in cortisol deficiency.
Valenzuela, G. A., Smalley, W. E., Schain, D. C., Vance, M. L., & McCallum, R. W. (1987) · PubMed · Cited by 23
Chong, J. S. W. L. V., Sen, J., Johnson, Z., Kyle, G., & MacFarlane, I. A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01200.x · Cited by 16
Cited by
Russell, G., & Lightman, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0228-0 · Cited by 1,032
Husebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403
Self-citationHusebye, E. S., Pearce, S. H., Krone, N. P., & Kämpe, O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00136-7 · Cited by 378
Self-citationHahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults
Betterle, C., Presotto, F., & Furmaniak, J. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01079-6 · Cited by 161
“Sometimes, AD can present with atypical manifestations of cerebral edema due to hyponatremia, persistent elevated transaminase levels associated with autoimmune hepatitis, anemia, vague abdominal pain, poor concentration and progressing fatigue [13].”
Background
Metadata
- Authors
- Björnsdottir, S., Sundström, A., Ludvigsson, J. F., Blomqvist, P., Kämpe, O., & Bensing, S.
- Affiliations
- Departments of Molecular Medicine and Surgery (S.Bj., S.Be.), SE-171 76 Stockholm, Sweden;
- Karolinska Institutet (SE)
- Uppsala University (SE)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-05-01
- Volume
- 98
- Issue
- 5
- Pages
- 2009-2018
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1996100128
- Cited by
- 70
- References
- 45
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 10 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 2
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk Fonden (NNF13OC0005975)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Addison's disease, prescribing patterns, cortisol, fludrocortisone, autoimmune disease comorbidity, gastrointestinal symptoms, anemia, antihypertensive drugs, cardiovascular drug use, replacement therapy
- MeSH terms
- Addison Disease, Adrenal Cortex Hormones, Adult, Antihypertensive Agents, Autoimmune Diseases, Diuretics, Female, Gastrointestinal Agents, Hematinics, Humans, Immunosuppressive Agents, Male, Middle Aged, Practice Patterns, Physicians', Drug Prescriptions, Registries, Sweden, Cohort Studies, Incidence, Prevalence, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.